KR20200124512A - Cosmetic composition - Google Patents
Cosmetic composition Download PDFInfo
- Publication number
- KR20200124512A KR20200124512A KR1020190047924A KR20190047924A KR20200124512A KR 20200124512 A KR20200124512 A KR 20200124512A KR 1020190047924 A KR1020190047924 A KR 1020190047924A KR 20190047924 A KR20190047924 A KR 20190047924A KR 20200124512 A KR20200124512 A KR 20200124512A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- salicylic acid
- oil
- formulation
- acne
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 126
- 239000002537 cosmetic Substances 0.000 title claims abstract description 85
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 71
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 36
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 26
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 24
- 239000008158 vegetable oil Substances 0.000 claims abstract description 24
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 13
- 238000006386 neutralization reaction Methods 0.000 claims description 22
- 239000003513 alkali Substances 0.000 claims description 16
- 235000019482 Palm oil Nutrition 0.000 claims description 10
- 239000002540 palm oil Substances 0.000 claims description 10
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- 230000001815 facial effect Effects 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 description 38
- 206010000496 acne Diseases 0.000 description 32
- 208000002874 Acne Vulgaris Diseases 0.000 description 31
- 238000009472 formulation Methods 0.000 description 28
- 238000001556 precipitation Methods 0.000 description 20
- 238000005187 foaming Methods 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 9
- 239000000344 soap Substances 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000012669 liquid formulation Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 5
- 238000005063 solubilization Methods 0.000 description 5
- 230000007928 solubilization Effects 0.000 description 5
- 241000186427 Cutibacterium acnes Species 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- -1 and at the same time Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 2
- SKIIKRJAQOSWFT-UHFFFAOYSA-N 2-[3-[1-(2,2-difluoroethyl)piperidin-4-yl]oxy-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound FC(CN1CCC(CC1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CC2=C(CC1)NN=N2)F SKIIKRJAQOSWFT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940102253 isopropanolamine Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NCXUNZWLEYGQAH-UHFFFAOYSA-N 1-(dimethylamino)propan-2-ol Chemical compound CC(O)CN(C)C NCXUNZWLEYGQAH-UHFFFAOYSA-N 0.000 description 1
- VIXJLJIOHUCFAI-UHFFFAOYSA-N 1-aminododecan-2-ol Chemical compound CCCCCCCCCCC(O)CN VIXJLJIOHUCFAI-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- LJDSTRZHPWMDPG-UHFFFAOYSA-N 2-(butylamino)ethanol Chemical compound CCCCNCCO LJDSTRZHPWMDPG-UHFFFAOYSA-N 0.000 description 1
- IWSZDQRGNFLMJS-UHFFFAOYSA-N 2-(dibutylamino)ethanol Chemical compound CCCCN(CCO)CCCC IWSZDQRGNFLMJS-UHFFFAOYSA-N 0.000 description 1
- GVNHOISKXMSMPX-UHFFFAOYSA-N 2-[butyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCN(CCO)CCO GVNHOISKXMSMPX-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 1
- 229940079779 disodium cocoyl glutamate Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940106026 phenoxyisopropanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229950009195 phenylpropanol Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940079988 potassium cocoyl glycinate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
본 기재는 화장료 조성물에 관한 것이다. The present description relates to a cosmetic composition.
일반적으로 피부는 접촉하는 다양한 자극을 효과적으로 방어하는 방어 기작을 가지고 있다. 그 중 대표적인 것이 최외각층에 존재하는 각질층인데, 이들은 외부의 자극 및 위험성분들을 효과적으로 막아주는 것과 동시에 땀, 피지 등 인체내부에서 발생되는 성분들과 외부의 먼지, 피부의 각질들이 뭉쳐 다양한 형태로 피부표면에 부착되어 있다. 이러한 오염물질을 제거하기 위해 많은 세정제품을 사용하고 있는데, 그 중 대표적인 것이 폼클렌져, 페이셜 클렌져, 바디클렌져, 바디워시 제품들이다. 이러한 세정제품들은 음이온 계면활성제를 주 계면활성제로 하여 피부표면의 다양한 오염물질들을 제거시켜준다. 하지만 음이온 계면활성제를 포함하는 대부분의 세정제품들은 피부의 오염물질뿐만 아니라 피부를 보호하는 제거하지 말아야 할 성분들까지 제거하게 된다. In general, the skin has a defense mechanism that effectively defends against various stimuli it comes into contact with. Representative of them is the stratum corneum, which is present in the outermost layer, which effectively blocks external irritation and dangerous ingredients, and at the same time, components generated inside the human body such as sweat and sebum, external dust, and dead skin cells gather to form various forms of skin. It is attached to the surface. Many cleaning products are used to remove such contaminants, and representative of them are foam cleanser, facial cleanser, body cleanser, and body wash. These cleaning products use anionic surfactant as the main surfactant to remove various contaminants from the skin surface. However, most cleaning products containing anionic surfactants remove not only contaminants from the skin, but also components that should not be removed that protect the skin.
예를 들면, 음이온 계면활성제를 포함하는 대부분의 세정제품들을 사용한 후 나타나는 현상 중 의외로 여드름이 발생된다는 임상실험 결과가 많다. 이는 피부외각의 보습층이 붕괴되어 그 속으로 화장료 조성물 내 성분들이 침투함으로써 발생되는 현상으로 심한 경우 피부의 터짐, 각질의 증가와 같은 현상이 함께 발생한다. 이러한 현상을 막기 위해서 음이온 계면활성제와 함께 보습성분을 추가하는 시도가 다양하게 있었으나, 여드름 증상 개선 효과는 미비하였다. 이에 세정 후, 바디로션 및 바디오일 등과 같은 보습화장료를 사용하여 적당한 보습을 유지하도록 함으로써 여드름 증상 개선 효과를 볼 수 있었는데, 이 경우 사용자가 세정 전과 후에 각각 다른 제품을 사용해야 하는 번거로움이 있어, 불편하다는 소비자들의 의견이 매우 많으며, 세정 후에도 별도의 제품 사용 없이도 적당한 보습이 유지되도록 하여 추가적인 보습 화장료를 사용하지 않아도 되는 클렌져에 대한 소비자들의 요구가 매우 높은 실정이다.For example, among the phenomena that appear after using most cleaning products containing anionic surfactants, there are many clinical trials that show that acne occurs unexpectedly. This is a phenomenon that occurs when the moisturizing layer on the outer surface of the skin collapses and the ingredients in the cosmetic composition penetrate into it. In severe cases, phenomena such as bursting of the skin and an increase in dead skin cells occur together. In order to prevent this phenomenon, there have been various attempts to add a moisturizing component together with an anionic surfactant, but the effect of improving acne symptoms was insufficient. Therefore, after washing, by using moisturizing cosmetics such as body lotion and body oil to maintain proper moisturization, the effect of improving acne symptoms could be seen.In this case, the user has to use different products before and after washing. There are a lot of opinions from consumers that it is, and consumers' demand for a cleanser that does not require the use of additional moisturizing cosmetics is very high by maintaining adequate moisturization even after washing without using a separate product.
일반적으로 여드름은 남성 호르몬 분비와 관련된 피지 과잉에 의해 발생하게 된다. 구체적으로는 남성 호르몬에 의해 피지가 발생되고 모공의 과각질화 현상(hyperkeratinization)이 유발되면서, 모공 입구가 좁아지거나 심한 경우 막히게 된다.In general, acne is caused by excess sebum related to male hormone secretion. Specifically, as sebum is generated by male hormones and hyperkeratinization of the pores is induced, the entrance of the pores is narrowed or clogged in severe cases.
또한, 모공 입구가 좁아지거나 막히게 되면, 모공 내의 피지가 외부로 배출되지 못하게 되면서 미세면포를 형성하게 되고, 모공 내에 서식하는 혐기성 박테리아인 프로피오니박테리움아크네스(propionibacterium acnes)가 증식하면서 염증이 유발될 수 있다.In addition, when the pore opening is narrowed or clogged, sebum in the pores is prevented from being discharged to the outside, forming micro-cotton vesicles, and propionibacterium acnes, an anaerobic bacterium living in the pores, proliferates, causing inflammation. Can be.
유발된 염증 반응으로 인해 홍반, 따끔거림, 또는 팽윤현상 등이 나타나며, 심한 경우 과색색소 침착(hyperpigmentation)이 나타날 수 있다. 또한, 여드름 부위를 짜거나 누르게 되면, 면포가 터지면서 염증이 악화되거나, 조직 손상을 일으키면서 여드름 흉터를 남길 위험이 커지게 된다.Erythema, tingling, or swelling may occur due to the induced inflammatory reaction, and in severe cases, hyperpigmentation may occur. In addition, when the acne area is squeezed or pressed, there is an increased risk of leaving acne scars while causing inflammation or tissue damage as the comedones burst.
이러한 여드름성 염증은, 다양한 원인에 의해 유발될 수 있으며, 예를 들어, 화장료 조성물 내에 함유된 각종 첨가제들이 피부에 남게 되면서 여드름성 염증을 유발할 수 있다. 또한, 체내에서 배출되는 피지, 땀 또는 자외선 등에 의해서도 피부 염증이 유발될 수 있다.Such acne-like inflammation may be caused by various causes, and, for example, various additives contained in a cosmetic composition may cause acne-like inflammation while remaining on the skin. In addition, skin inflammation may be caused by sebum, sweat, or ultraviolet rays discharged from the body.
그 동안 여드름에 대한 접근은 다방면에서 이루어져 왔으나 클렌져로 기능하면서 여드름 증상을 개선시키는 제품은 미비한 실정이다.Until now, approaches to acne have been made in many ways, but there are insufficient products that function as cleansers and improve acne symptoms.
따라서, 세정력이 우수하고 보습력을 뛰어나 여드름 증상 개선에 효과가 있으면서 동시에 세정 후 별도의 제품 사용이 불요한 클렌져 화장료 조성물에 대한 연구가 계속되고 있다.Therefore, research on a cleanser cosmetic composition that is excellent in cleaning power and excellent in moisturizing power, which is effective in improving acne symptoms and at the same time, requires no use of a separate product after cleaning, continues.
일 구현예는 저온안정성 및 기포력이 우수하고, 완전히 투명한 외관을 가지는, 여드름 기능성 클렌져 화장료 조성물을 제공하려는 것이다.One embodiment is to provide an acne functional cleanser cosmetic composition having excellent low-temperature stability and foaming power, and having a completely transparent appearance.
일 구현예에 따르면, 식물성 오일; 알칼리제; 설테인계 양쪽성 계면활성제; 살리실산; 및 용매를 포함하는 화장료 조성물을 제공한다. According to one embodiment, vegetable oil; Alkaline agents; Sultain-based amphoteric surfactant; Salicylic acid; And it provides a cosmetic composition comprising a solvent.
상기 식물성 오일은 야자유, 팜유, 피마자유, 올리브유 또는 이들의 조합을 포함할 수 있다.The vegetable oil may include palm oil, palm oil, castor oil, olive oil, or a combination thereof.
상기 식물성 오일은 상기 화장료 조성물 총량에 대해 5 중량% 내지 70 중량%로 포함될 수 있다.The vegetable oil may be included in an amount of 5% to 70% by weight based on the total amount of the cosmetic composition.
상기 알칼리제는 KOH일 수 있다.The alkali agent may be KOH.
상기 알칼리제는 92% 내지 100%의 중화도를 가질 수 있다.The alkali agent may have a degree of neutralization of 92% to 100%.
상기 설테인계 양쪽성 계면활성제는 상기 화장료 조성물 총량에 대해 10 중량% 내지 40 중량%로 포함될 수 있다.The sultein-based amphoteric surfactant may be included in an amount of 10% to 40% by weight based on the total amount of the cosmetic composition.
상기 살리실산은 상기 화장료 조성물 총량에 대해 0.5 중량% 내지 2 중량%로 포함될 수 있다.The salicylic acid may be included in an amount of 0.5% to 2% by weight based on the total amount of the cosmetic composition.
상기 화장료 조성물은 투명할 수 있다.The cosmetic composition may be transparent.
상기 화장료 조성물은 클렌져 화장료 조성물일 수 있다.The cosmetic composition may be a cleanser cosmetic composition.
상기 화장료 조성물은 페이셜 클렌져 화장료 조성물 또는 바디 클렌져 화장료 조성물일 수 있다.The cosmetic composition may be a facial cleanser cosmetic composition or a body cleanser cosmetic composition.
다른 일 구현예는 상기 화장료 조성물을 포함하는 클렌져를 제공한다.Another embodiment provides a cleanser comprising the cosmetic composition.
상기 클렌져는 페이셜 클렌져 또는 바디 클렌져일 수 있다.The cleanser may be a facial cleanser or a body cleanser.
일 구현예에 따른 화장료 조성물은 살리실산을 포함하여 여드름 기능성을 가지면서도, 저온안정성과 기포력이 우수하고, 투명한 외관을 가질 수 있다.The cosmetic composition according to the embodiment may include salicylic acid, have acne functionality, have excellent low-temperature stability and foaming power, and have a transparent appearance.
이하, 본 발명의 구현예에 대하여 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 구현예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those of ordinary skill in the art may easily implement the present invention. However, the present invention may be implemented in various different forms, and is not limited to the embodiments described herein.
본 명세서에서 "투명하다"라 함은 조성물 등의 용액이 속까지 환히 비치도록 맑은 상태를 의미한다.In the present specification, "transparent" means a clear state so that a solution such as a composition is reflected brightly to the inside.
본 명세서에서 층, 막, 영역, 판 등의 부분이 다른 부분 "위에" 있다고 할 때, 이는 다른 부분 "바로 위에" 있는 경우뿐만 아니라 그 중간에 또 다른 부분이 있는 경우도 포함한다. 반대로 어떤 부분이 다른 부분 "바로 위에" 있다고 할 때에는 중간에 다른 부분이 없는 것을 뜻한다.In the present specification, when a portion such as a layer, a film, a region, or a plate is said to be “on” another portion, this includes not only the case where the other portion is “directly above” but also the case where there is another portion in the middle. Conversely, when one part is "right above" another part, it means that there is no other part in the middle.
이하 일 구현예에 따른 화장료 조성물에 대해 설명한다.Hereinafter, a cosmetic composition according to an embodiment will be described.
살리실산은 의약외품에서 가장 널리 사용되는 여드름 치료용 주성분이며 장기간 사용하여도 피부에 부담을 주지 않고 피부의 재생 속도를 빠르게 하여 피부의 모공이 막히는 것을 방지해 주는 효과를 갖는다. 따라서 모공의 막힘을 방지하고 여드름 증상을 완화시키는 목적으로 널리 사용되어 왔다. 실제로 살리실산이 의약외품에 포함될 경우, 상기 의약외품은 한국 식약처로부터 여드름 기능성을 인정받고 있다.Salicylic acid is the most widely used main ingredient for acne treatment in quasi-drugs and has the effect of preventing clogging of pores by speeding up skin regeneration without burdening the skin even after long-term use. Therefore, it has been widely used to prevent clogging of pores and relieve acne symptoms. In fact, when salicylic acid is included in a quasi-drug, the quasi-drug is recognized for acne functionality from the Korean Food and Drug Administration.
즉, 살리실산이 의약외품이 아닌 화장료 조성물을 구성하는 구성성분으로 사용될 경우에는 여드름 기능성을 인정받을 수 없었다. 그러나, 최근들어 살리실산을 포함하는 화장품 조성물도 한국 식약처로부터 여드름 기능성을 인정받을 수 있게 되었으며, 이에 의해 살리실산을 포함하는 클렌져 화장료 조성물이 다수 개발되어 시장에 제품으로 출시될 것으로 예상되었으나, 예상과 달리 살리실산을 포함하는 여드름 기능성 클렌져는 종래와 다를 바가 없는 게 현재까지의 상황이다. That is, when salicylic acid was used as a component constituting a cosmetic composition other than a quasi-drug, acne functionality could not be recognized. However, recently, cosmetic compositions containing salicylic acid have been able to be recognized for acne functionality from the Korean Food and Drug Administration, and by this, a number of cleanser cosmetic compositions containing salicylic acid have been developed and are expected to be released as products on the market. Acne functional cleansers containing salicylic acid are the same as before.
이는 현재 클렌져 화장료 조성물에 살리실산이 포함될 경우 여드름 기능성 허가를 받을 수 있으나, 살리실산은 소수성이 강하여 물이 많이 포함된 액상 클렌져에서는 안정도가 좋지 않으며, 특히 저온에서는 석출현상까지 나타나기 때문에, 살리실산을 포함하는 클렌져 화장료 조성물의 개발이 어렵기 때문이다. If salicylic acid is included in the current cleanser cosmetic composition, acne functional license can be obtained, but salicylic acid is highly hydrophobic, so stability is not good in liquid cleansers containing a lot of water, and especially precipitation occurs at low temperatures, so cleansers containing salicylic acid This is because it is difficult to develop a cosmetic composition.
기존에는 상기 문제점을 해결하기 위해 폴리올을 다량 처방하여 저온석출을 방지하였지만, 폴리올 함량이 높아지면 기포생성을 저해하여 기포력이 좋지 않고 조성물의 점도가 너무 낮아져 조성물 토출 시 품질이 좋지 않는 다른 문제점이 발생하게 된다. 그리고 석출현상으로 인해 투명한 조성물을 만드는 것에도 한계가 있다.Conventionally, in order to solve the above problem, a large amount of polyol was prescribed to prevent low-temperature precipitation, but when the polyol content increased, the foaming ability was poor and the viscosity of the composition was too low to prevent the generation of bubbles, resulting in other problems of poor quality when discharging the composition. Will occur. And there is a limit to making a transparent composition due to the precipitation phenomenon.
이에 본 발명자들은 오랜 연구 끝에, 화장료 조성물에 살리실산을 포함시킴으로써 여드름 기능성 허가를 받을 수 있으며, 동시에 기포력과 저온안정성이 우수하고, 조성물 토출 품질 또한 우수한 액상의 클렌져용 투명 화장료 조성물에 개발하기에 이르었다.Accordingly, the inventors of the present invention have developed a transparent cosmetic composition for liquid cleanser that can obtain acne functionality by including salicylic acid in the cosmetic composition, and at the same time has excellent foaming power and low temperature stability, and excellent composition discharge quality. Done.
일 구현예에 따른 화장료 조성물은 살리실산을 포함하여 여드름 개선에 효과가 있으며, 제형의 살리실산 용해력을 높여 저온 안정도를 향상시킬 수 있고, 살리실산 용해를 위해 종래와 같이 폴리올을 사용하지 않아 기포력을 개선시킬 수 있으며, 조성물의 점도가 높아 조성물 토출 시 튀지 않으며 안정적으로 토출이 가능하다. 나아가, 용해도가 우수해 투명한 제형으로 제조가 가능하기에 제품으로 시장에 출시 시 사용자들에게 우수한 관능감을 제공할 수도 있다.The cosmetic composition according to an embodiment is effective in improving acne, including salicylic acid, and improves low-temperature stability by increasing the salicylic acid dissolution power of the formulation, and does not use polyols as in the prior art for salicylic acid dissolution, thus improving foaming power. In addition, the viscosity of the composition is high, so it does not splash when the composition is discharged and can be discharged stably. Furthermore, since it has excellent solubility and can be manufactured in a transparent formulation, it can also provide excellent sensory feeling to users when it is released to the market as a product.
구체적으로, 일 구현예에 따른 화장료 조성물은 식물성 오일을 포함한다.Specifically, the cosmetic composition according to one embodiment includes a vegetable oil.
상기 식물성 오일은 불검화물이 적은 단쇄 지방산 또는 불포화 지방산이 적은 오일, 예컨대 야자유, 팜유, 피마자유, 올리브유 또는 이들의 조합을 포함할 수 있다. 예컨대, 상기 식물성 오일로 불검화물이 많거나 탄화수소 사슬이 긴 장쇄 지방산이나 불포화 지방산이 많은 오일을 사용할 경우 최종적으로 제조되는 조성물의 기포력을 저하시켜 바람직하지 않을 수 있다.The vegetable oil may include short-chain fatty acids with less unsaponifiable matter or oil with less unsaturated fatty acids, such as palm oil, palm oil, castor oil, olive oil, or a combination thereof. For example, when using an oil containing a large amount of unsaponifiable or a long-chain fatty acid or an unsaturated fatty acid having a long hydrocarbon chain as the vegetable oil, it may be undesirable because the foaming power of the finally prepared composition is reduced.
예컨대, 상기 식물성 오일은 상기 화장료 조성물 총량에 대해 5 중량% 내지 70 중량%로 포함될 수 있다. 상기 식물성 오일이 상기 범위로 포함될 경우 기포력이 우수한 제형 형성에 유리할 수 있다. 예컨대 상기 식물성 오일이 상기 화장료 조성물 총량에 대해 5 중량% 미만으로 포함될 경우 기포가 거의 없어 검화에 의해 생성되는 솝의 함량이 너무 적어지게 되는데, 이렇게 적은 양의 솝이 함께 사용된 살리실산의 안정화에 사용되기에 솝 특유의 기포력이 발생하지 않게 되고, 상기 식물성 오일이 상기 화장료 조성물 총량에 대해 70 중량% 초과로 포함될 경우 오일 함량이 너무 과해 액상제형화 자체가 불가하다.For example, the vegetable oil may be included in an amount of 5% to 70% by weight based on the total amount of the cosmetic composition. When the vegetable oil is included in the above range, it may be advantageous to form a formulation having excellent foaming power. For example, if the vegetable oil is contained in an amount of less than 5% by weight based on the total amount of the cosmetic composition, the amount of soap produced by saponification becomes too small because there are few air bubbles.This small amount of soap is used to stabilize the used salicylic acid. Therefore, the foaming force peculiar to soap does not occur, and when the vegetable oil is included in an amount of more than 70% by weight based on the total amount of the cosmetic composition, the oil content is too high, so that liquid formulation itself is impossible.
일 구현예에 따른 화장료 조성물은 알칼리제를 포함함으로써 제형 안정성을 가질 수 있다. 상기 알칼리제가 없을 경우, 제형 자체가 형성되지 않는다.The cosmetic composition according to an embodiment may have formulation stability by including an alkali agent. In the absence of the alkali agent, the formulation itself is not formed.
예컨대, 상기 알칼리제는 KOH일 수 있다. 상기 알칼리제로 KOH를 사용할 경우, 다른 종류의 알칼리염을 사용하는 경우와 비교하여, 액상 제형의 제조가 용이하며, 인체 안전성도 우수할 수 있다. 예컨대, 상기 알칼리제로 NaOH를 사용할 경우 딱딱한 Soap-bar(고체비누)가 되어 액상 제형의 제조가 어려우며, 상기 알칼리제로 트리에탄올아민을 사용할 경우 액상 혹은 페이스트상은 만들 수 있으나, 발암물질인 나이트로사민 이슈가 발생될 염려가 매우 크다. For example, the alkali agent may be KOH. When KOH is used as the alkali, compared to the case of using other types of alkali salts, the preparation of a liquid formulation is easy and human safety may be excellent. For example, when NaOH is used as the alkali, it becomes a hard soap-bar (solid soap), which makes it difficult to manufacture a liquid formulation.When triethanolamine is used as the alkali, a liquid or paste can be made, but nitrosamine, a carcinogen, is a problem. There is a great deal of concern.
예컨대, 상기 알칼리제는 92% 내지 100%의 중화도를 가질 수 있다. 상기 알칼리제가 상기 범위의 중화도를 가져야 최종적으로 제조되는 조성물의 기포력이 우수할 수 있다. 예컨대 상기 알칼리제의 중화도가 92% 미만이거나 100% 초과일 경우 최종적으로 제조되는 조성물의 기포력이 저하될 수 있어 바람직하지 않을 수 있다.For example, the alkali agent may have a degree of neutralization of 92% to 100%. When the alkali agent has a degree of neutralization within the above range, the foaming power of the finally prepared composition may be excellent. For example, when the neutralization degree of the alkali agent is less than 92% or more than 100%, the foaming power of the finally prepared composition may be lowered, which may be undesirable.
상기 알칼리제의 중화도는 알칼리제의 함량 및 함께 사용되는 식물성 오일의 종류에 따라 상이해질 수 있는데, 상기 식물성 오일로 야자유, 팜유, 피마자유, 올리브유 또는 이들의 조합을 사용할 경우, 함께 사용되는 알칼리제의 함량은 상기 화장료 조성물 총량 대비 0.8 중량% 내지 13 중량%로 포함될 수 있다.The degree of neutralization of the alkali agent may vary depending on the content of the alkali agent and the type of vegetable oil used together.When using palm oil, palm oil, castor oil, olive oil or a combination thereof as the vegetable oil, the content of the alkali agent used together May be included in 0.8% to 13% by weight based on the total amount of the cosmetic composition.
일 구현예에 따른 화장료 조성물은 설테인계 양쪽성 계면활성제를 포함한다. 상기 설테인계 양쪽성 계면활성제는 최종적으로 제조되는 화장료 조성물의 저온안정성을 향상시키고, 투명한 제형을 가능하게 한다.The cosmetic composition according to one embodiment includes a sultein-based amphoteric surfactant. The sultein-based amphoteric surfactant improves the low-temperature stability of the finally prepared cosmetic composition and enables a transparent formulation.
예컨대, 상기 설테인계 양쪽성 계면활성제가 아닌 화합물을 계면활성제로 사용할 경우 가용화력이 부족하여 제형이 불투명해지거나, 투명하여도 저온안정성이 저하되어 바람직하지 않을 수 있다.For example, when a compound other than the sultein-based amphoteric surfactant is used as a surfactant, the formulation may become opaque due to insufficient solubilization power, or even if transparent, low-temperature stability may be deteriorated, which may be undesirable.
예컨대, 상기 설테인계 양쪽성 계면활성제는 상기 화장료 조성물 총량 대비 10 중량% 내지 40 중량%로 포함될 수 있다. 상기 설테인계 양쪽성 계면활성제가 상기 범위로 포함됨으로써 가용화력이 풍부해져 저온안정성 및 투명성이 우수해질 수 있다. 예컨대, 상기 설테인계 양쪽성 계면활성제가 상기 화장료 조성물 총량에 대해 10 중량% 미만으로 포함될 경우 가용화력이 부족해 저온안정성이 저하되며, 상기 설테인계 양쪽성 계면활성제가 상기 화장료 조성물 총량에 대해 40 중량% 초과로 포함될 경우 조성물의 점도가 지나치게 높아져 서로 엉기면서 액상이 아닌 페이스트상으로 변하게 되어 바람직하지 않을 수 있다.For example, the sultein-based amphoteric surfactant may be included in an amount of 10% to 40% by weight based on the total amount of the cosmetic composition. When the sultein-based amphoteric surfactant is included in the above range, solubilization power is enriched, so that low-temperature stability and transparency may be excellent. For example, when the sultein-based amphoteric surfactant is contained in an amount of less than 10% by weight based on the total amount of the cosmetic composition, low-temperature stability is reduced due to insufficient solubilization power, and the sultein-based amphoteric surfactant is 40% by weight based on the total amount of the cosmetic composition. If it is included in excess, the viscosity of the composition becomes too high, so that the composition changes to a paste form rather than a liquid form while being coagulated with each other, which may be undesirable.
일 구현예에 따른 화장료 조성물은 살리실산을 포함함으로써 여드름 증상 개선 효과를 가질 수 있다.The cosmetic composition according to the embodiment may have an effect of improving acne symptoms by including salicylic acid.
예컨대, 상기 살리실산은 상기 화장료 조성물 총량에 대해 0.5 중량% 내지 2 중량%로 포함됨으로써, 여드름 기능성과 제형 안정성을 모두 만족시킬 수 있다. 예컨대, 상기 살리실산이 상기 화장료 조성물 총량에 대해 0.5 중량% 미만으로 포함될 경우 여드름 증상 개선 효과가 매우 미미하며, 상기 살리실산이 상기 화장료 조성물 총량에 대해 2 중량% 초과로 포함될 경우 석출 현상이 발생하면서 제형화가 어려워지게 되어 바람직하지 않을 수 있다. 예전에는 화장료 조성물에 살리실산이 사용될 경우 그 함량이 화장료 조성물 총량 대비 약 0.5 중량% 이하로 포함되었는데, 이는 화장품 범규에 따른 것이었다. 그러나, 최근 의약외품이 아닌 화장품에 살리실산을 첨가하더라도 피부 자극 우려가 없을 경우 한국 식약처로부터 여드름 기능성을 인정받을 수 있게 되었고, 일 구현예는 화장료 조성물 총량 대비 살리실산을 0.5 중량% 내지 2 중량%의 함량으로 포함함으로써, 피부 자극이 없으면서도 여드름 증상 개선에 우수한 효과를 보이고, 동시에 석출없이 투명한 제형의 화장료 조성물을 제공할 수 있다.For example, the salicylic acid may be included in an amount of 0.5% to 2% by weight based on the total amount of the cosmetic composition, thereby satisfying both acne functionality and formulation stability. For example, when the salicylic acid is included in an amount of less than 0.5% by weight of the total amount of the cosmetic composition, the effect of improving acne symptoms is very insignificant, and when the salicylic acid is included in an amount of more than 2% by weight of the total amount of the cosmetic composition, precipitation occurs and formulation is difficult. It becomes difficult and can be undesirable. In the past, when salicylic acid was used in a cosmetic composition, its content was included in about 0.5% by weight or less of the total amount of the cosmetic composition, which was in accordance with the cosmetic regulations. However, in recent years, even if salicylic acid is added to cosmetics other than quasi-drugs, if there is no concern for skin irritation, acne functionality has been recognized by the Korean Food and Drug Administration, and in one embodiment, salicylic acid is contained in an amount of 0.5% to 2% by weight relative to the total amount of the cosmetic composition By including as, it is possible to provide a cosmetic composition having a transparent formulation without skin irritation, showing an excellent effect in improving acne symptoms, and at the same time without precipitation.
또한, 일 구현예에 따른 화장료 조성물은 전술한 성분 이외에 기본적인 물성 및 품질을 유지하기 위한 통상적인 임의 성분으로서 당해 분야의 전문가에게 널리 공지되어 사용되는 성분들을 포함할 수 있으며, 예컨대 컨디셔닝제, 펄화제, 방부제, 점증제, 점도조절제, pH조절제, 향료 등이 추가로 함유될 수 있으며, 용제로서 탈이온수 등이 함유될 수 있다.In addition, the cosmetic composition according to an embodiment may include ingredients widely known and used by experts in the field as conventional optional ingredients for maintaining basic physical properties and quality in addition to the aforementioned ingredients, such as conditioning agents, pearlizing agents , Preservatives, thickeners, viscosity modifiers, pH modifiers, fragrances, etc. may be additionally contained, and deionized water may be contained as a solvent.
상기 컨디셔닝제로는 디메치콘 베이스, 수소화된 폴리데센 및 양이온성 폴리머로 이루어진 군에서 선택하여 사용할 수 있다.The conditioning agent may be selected from the group consisting of dimethicone base, hydrogenated polydecene, and cationic polymer.
상기 펄화제로는 글라이콜디스테아레이트, 글라이콜모노스테아레이트, 지방산 등을 사용할 수 있다.As the pearling agent, glycol distearate, glycol monostearate, fatty acids, and the like may be used.
상기 방부제는 파라옥시안식향산메틸, 메칠파라벤, 부틸파라벤, 에칠파라벤, 프로필파라벤, 벤질알코올, 페녹시에탄올, 페녹시이소프로판올, 페닐프로판올, 메틸클로로이소티아졸리논 및 메틸이소티아졸리논의 혼합물을 포함할 수 있다.The preservative may include a mixture of methyl paraoxybenzoate, methylparaben, butylparaben, ethylparaben, propylparaben, benzyl alcohol, phenoxyethanol, phenoxyisopropanol, phenylpropanol, methylchloroisothiazolinone and methylisothiazolinone. I can.
상기 점증제 또는 점도조절제는 지방산 알코올, 지방산, 하이드록시프로필메틸셀룰로오스, 하이드록시메틸셀룰로오스, 염화나트륨, 염화암모늄 등을 포함할 수 있다.The thickener or viscosity modifier may include fatty alcohol, fatty acid, hydroxypropylmethylcellulose, hydroxymethylcellulose, sodium chloride, ammonium chloride, and the like.
상기 pH조절제는 아세트산, 락트산, 아디프산, 아스코르브산, 아제라산(Azelaic acid), 벤조산, 부틸 디에탄올 아민, 부틸에탄올아민, 시트르산, 디부틸 에탄올아민, 디에탄올아민, 디이소프로필아민, 디이소프로판올아민, 디메틸 이소프로판올아민, 데틸에탄올아민, 갈락투론산(Galacturonic acid), 글리콜산(Glycolic acid), 이소프로판올아민, 이소프로필아민, 말산, 말론산(Malonic acid) 및 메틸에탄올아민(Methylethanolamine)를 포함할 수 있다.The pH adjusting agent is acetic acid, lactic acid, adipic acid, ascorbic acid, azelaic acid, benzoic acid, butyl diethanolamine, butylethanolamine, citric acid, dibutyl ethanolamine, diethanolamine, diisopropylamine, di. Includes isopropanolamine, dimethyl isopropanolamine, decylethanolamine, galacturonic acid, glycolic acid, isopropanolamine, isopropylamine, malic acid, malonic acid, and methylethanolamine can do.
또한, 추가적으로 함유 가능한 성분 중 색소는 일반적인 세정 제제에 사용되는 성분들을 특별한 제한없이 사용할 수 있다.In addition, among the components that can be additionally contained, the components used in general cleaning formulations may be used without particular limitation as the pigment.
일 구현예에 따른 화장료 조성물은 투명 화장료 조성물로서, 투명한 클렌져 화장료 조성물, 예컨대 투명 페이셜 클렌져 화장료 조성물 또는 투명 바디 클렌져 화장료 조성물 등 세정제에 사용될 수 있는 모든 제형으로 적용될 수 있다. 이때 제형화하는 방법은 특별히 한정되지 않고 해당 분야에서 공지된 일반적인 방법들을 제한없이 사용할 수 있다.The cosmetic composition according to an embodiment is a transparent cosmetic composition, and may be applied in any formulation that can be used in a detergent, such as a transparent cleanser cosmetic composition, such as a transparent facial cleanser cosmetic composition or a transparent body cleanser cosmetic composition. At this time, the method of formulating is not particularly limited, and general methods known in the field may be used without limitation.
한편, 일 구현예에 따른 화장료 조성물이 거품 형태의 에어로졸 컨디셔닝 조성물로 사용될 경우, 분사제를 더 포함할 수 있으며, 상기 분사제는 종래에 에어로졸 화장료 조성물에 일반적으로 사용된 분사제라면 어떠한 것도 포함될 수 있다.On the other hand, when the cosmetic composition according to an embodiment is used as a foam-type aerosol conditioning composition, it may further include a propellant, and the propellant may contain any propellant if it is a propellant generally used in a conventional aerosol cosmetic composition. have.
이하 실시예를 통하여 상술한 본 발명의 구현예를 보다 상세하게 설명한다. 다만 하기의 실시예는 단지 설명의 목적을 위한 것이며 본 발명의 범위를 제한하는 것은 아니다.The embodiments of the present invention described above will be described in more detail through the following examples. However, the following examples are for illustrative purposes only and do not limit the scope of the present invention.
화장료 조성물 제조Preparation of cosmetic composition
하기 표 1 내지 표 6과 같은 조성과 함량으로 제조예 1 내지 제조예 48을 제조하였다. 원료는 순서대로 분산 투입하고, 각 원료 투입 후 균일상이 될 때까지 교반하였으며, 상기 제조예들의 제조방법은 당업계에서 통상적으로 제조하는 방법에 의하였다.Preparation Examples 1 to 48 were prepared with the composition and contents shown in Tables 1 to 6 below. The raw materials were sequentially dispersed and added, and stirred until a homogeneous phase was obtained after each raw material was added, and the manufacturing method of the above preparation examples was a method conventionally prepared in the art.
Salicylic acid
평가 1: 액상 제형 형성성, 기포력, 투명도 및 저온안정도Evaluation 1: Liquid formulation formation, foaming power, transparency and low temperature stability
제조예 1 내지 제조예 48의 화장료 조성물 각각에 대해 기포력, 투명도 및 저온안정도를 측정하여 그 결과를 하기 표 7 내지 표 12에 나타내었다. 기포력은 Dynamic Foam Analyzer (DFA100, KRUSS, 측정단위 mm)을 이용하여 기포력을 측정하였고, 투명도는 LED가 장착된 포토박스에서 투명도를 측정하였고, 저온안정도는 화장료 조성물을 24시간 동결 진행 후 해동된 상태에서 석출 여부로 판단하였다. Foaming power, transparency, and low temperature stability were measured for each of the cosmetic compositions of Preparation Examples 1 to 48, and the results are shown in Tables 7 to 12 below. Foaming force was measured using Dynamic Foam Analyzer (DFA100, KRUSS, measurement unit mm), and transparency was measured in a photobox equipped with an LED, and low temperature stability was determined by freezing the cosmetic composition for 24 hours and then thawing it. It was judged by the presence of precipitation in the state.
(○: 제형화 가능 / X: 제형화 불가능)(○: formulation possible / X: formulation impossible)
제조예 1 및 제조예 2는 검화에 의해 생성되는 솝의 함량이 너무 적었다. 게다가 생성된 솝도 살리실산의 안정화에 사용되어 솝 특유의 기포력이 나타나지않고 쉽게 기포가 사라짐을 확인할 수 있었다. 제조예 3 내지 제조예 7은 오일 함량이 늘어 기포력도 좋아지지만, 제조예 8 및 제조예 9에서는 솝의 함량이 너무 많아져서 액상제형화가 불가능했다.In Preparation Example 1 and Preparation Example 2, the amount of soap produced by saponification was too small. In addition, the generated soap was also used for stabilization of salicylic acid, so it could be confirmed that the bubbles disappeared easily without the specific bubble power of the soap. In Preparation Examples 3 to 7, the oil content increased and the foaming power was improved, but in Preparation Examples 8 and 9, the amount of soap was too high, so that liquid formulation was impossible.
제조예 5 및 제조예 10 내지 제조예 12는 기포가 많이 생성됨을 확인하였다. 그러나 제조예 13 내지 제조예 15의 경우, 기포가 충분하지 않았고 쉽게 꺼지는 것을 확인할 수 있었는데, 이로부터 같은 식물성 오일이더라도 불검화물이 많거나 탄화수소 사슬이 긴 장쇄지방산이거나 혹은 불포화 지방산이 많은 오일을 식물성 오일로 사용할 경우 기포가 많이 나지 않아 기포력이 저하됨을 알 수 있었다.In Preparation Example 5 and Preparation Example 10 to Preparation Example 12, it was confirmed that many air bubbles were generated. However, in the case of Preparation Examples 13 to 15, it was confirmed that the air bubbles were insufficient and disappeared easily.From this, even though the same vegetable oil, a long-chain fatty acid having a long hydrocarbon chain or a long-chain fatty acid having a long hydrocarbon chain, or an oil having a large amount of unsaturated fatty acid was used as a vegetable oil. When used as, it was found that the foaming power was lowered because there were not many air bubbles.
KOH 중화율에 따른 기포력을 비교하였을 때, 제조예 16, 제조예 17 및 제조예 23은 기포가 충분하게 발생하지 않았다. 그리고 제조예 24처럼 KOH가 없으면 제형이 만들어지지 않았다.When comparing the foaming force according to the KOH neutralization rate, Preparation Example 16, Preparation Example 17, and Preparation Example 23 did not sufficiently generate bubbles. And, as in Preparation Example 24, without KOH, the formulation was not made.
한편, KOH가 살리실산 중화에도 사용되면서 기포력은 제조예 18 내지 제조예 22와 같이 솝 기준 중화율 100%까지 올려도 충분히 기포가 생성되었다.On the other hand, as KOH was also used for salicylic acid neutralization, bubbles were sufficiently generated even if the foaming power was increased to 100% of the soap standard neutralization rate as in Preparation Examples 18 to 22.
계면활성제별로 제형의 저온안정도 및 투명도를 확인하였는데, 제조예 32 내지 제조예 34의 경우 가용화력이 부족하여 제형이 불투명하거나, 혹은 제조예 25 내지 제조예 31처럼 투명하여도 저온에서의 안정도가 충분하지 않았다. 제조예 5의 경우 투명한 제형이 만들어지며 저온에서의 안정도도 뛰어남을 확인 할 수 있었다.Low-temperature stability and transparency of the formulation were confirmed for each surfactant. In Preparation Examples 32 to 34, the formulation was opaque due to insufficient solubilization power, or even if the formulation was transparent as in Preparation Examples 25 to 31, stability at low temperatures was sufficient. Did not do it. In the case of Preparation Example 5, it was confirmed that a transparent formulation was made and stability at low temperature was excellent.
(○: 제형화 가능 / X: 제형화 불가능)(○: formulation possible / X: formulation impossible)
설테인계 계면활성제가 가용화력 및 안정도에 도움이 되기 위해서는 제조예 37과 같이 (화장료 조성물 총량 대비) 최소 10 중량% 정도의 함량이 필요함을 확인할 수 있었다. 제조예 40과 같이 (화장료 조성물 총량 대비) 40 중량%까지도 저온안정도 및 투명도가 좋은 액상이 되지만, 제조예 41 및 제조예 42와 같이 그 이상의 함량이 들어가게 되면, 액상이 아닌 내용물이 엉기면서 페이스트 상으로 변한다. 이는 액상이 되기 위한 용매인 D.I.Water의 함량이 줄어들면서 펌프가 안되는 페이스트 상으로 변하기 때문이다.In order for the sultein-based surfactant to help in solubilization power and stability, it was confirmed that a content of at least 10% by weight (relative to the total amount of the cosmetic composition) was required as in Preparation Example 37. As in Preparation Example 40 (relative to the total amount of the cosmetic composition), a liquid with good low-temperature stability and transparency is obtained, but when more than that is added, as in Preparation Examples 41 and 42, the contents, not the liquid state, are condensed into a paste form. Turns into This is because the content of D.I.Water, which is a solvent for liquid phase, decreases, and it changes into a paste form that cannot be pumped.
(○: 제형화 가능 / X: 제형화 불가능)(○: formulation possible / X: formulation impossible)
제조예 43 내지 제조예 46 및 제조예 5는 투명한 제형을 만들 수가 있었으나, 제조예 47 및 제조예 48은 석출이 일어나 제형화가 불가한 것을 확인할 수 있었다.Preparation Examples 43 to 46 and Preparation Example 5 was able to make a transparent formulation, but Preparation Example 47 and Preparation Example 48 was confirmed that the formulation was impossible due to precipitation.
평가 2: 여드름 생성 억제 효과Evaluation 2: Inhibitory effect of acne generation
여드름 생성 억제 효과 측정을 위해 대표적인 여드름 유발균인 프로피오니박테리움 아크네스와 스타필로코커스 아우레우스에 대한 항균 효과를 측정하였다.In order to measure the anti-acne production inhibitory effect, the antibacterial effect was measured against Propionibacterium acnes and Staphylococcus aureus, which are representative acne-causing bacteria.
구체적으로, 프로피오니박테리움 아크네스와 스타필로코커스 아우레우스를 상온 조건으로 BHI 배지에 접종하고, 상기 배지에 제조예 43 내지 제조예 48 및 제조예 5에 따른 조성물을 3.0㎍/ml 농도로 희석한 분산액을 처리한 직경 6mm의 페이퍼 디스크를 올려놓은 다음 37℃에서 24시간 반응시켜, 투명환의 크기 비교로 향균력을 평가하였다. 그 결과는 하기 표 13에 나타내었다.Specifically, Propionibacterium acnes and Staphylococcus aureus were inoculated into a BHI medium under room temperature conditions, and the compositions according to Preparation Examples 43 to 48 and 5 were diluted to a concentration of 3.0 μg/ml in the medium. A paper disk having a diameter of 6 mm treated with one dispersion was placed on it, and then reacted at 37° C. for 24 hours, and the antibacterial power was evaluated by comparing the size of the transparent ring. The results are shown in Table 13 below.
(X: 투명환이 형성되지 않음, ○: 투명환 생성, ◎: 매우 강한 투명환 생성) (X: transparent ring is not formed, ○: transparent ring is generated, ◎: very strong transparent ring is generated)
제조예 43 및 제조예 44는 여드름 개선 실효능이 충분치 않은 반면, 제조예 45, 제조예 46 및 제조예 5는 프로피오니박테리움 아크네스와 스타필로코커스 아우레우스에 대한 항균력이 우수하여, 항여드름 효과를 가짐을 확인할 수 있다. 다만, 제조예 47 및 제조예 48은 석출 현상 발생으로 인해 제형화가 불가하여 여드름 개선 효능을 측정할 수 없었다. 또한, 제조예 47 및 제조예 48은 살리실산을 조성물 총량 대비 2 중량% 초과의 함량으로 사용하기에 피부 자극에 대한 염려도 있어 이를 화장료 조성물로 사용하기에는 적절하지 않다.Preparation Example 43 and Preparation Example 44 did not have sufficient effectiveness in improving acne, whereas Preparation Example 45, Preparation Example 46, and Preparation Example 5 had excellent antibacterial activity against Propionibacterium acnes and Staphylococcus aureus, anti-acne It can be confirmed that it has an effect. However, Preparation Example 47 and Preparation Example 48 could not be formulated due to the occurrence of the precipitation phenomenon, so the acne improvement efficacy could not be measured. In addition, since Preparation 47 and Preparation 48 use salicylic acid in an amount greater than 2% by weight relative to the total amount of the composition, there is also concern about skin irritation, and thus it is not suitable for use as a cosmetic composition.
이상에서 본 발명의 바람직한 실시예들에 대하여 상세하게 설명하였지만 본 발명의 권리 범위는 이에 한정되는 것은 아니고 다음의 청구 범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리 범위에 속하는 것이다.Although the preferred embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements by those skilled in the art using the basic concept of the present invention defined in the following claims are also present. It belongs to the scope of the invention.
Claims (10)
알칼리제;
설테인계 양쪽성 계면활성제;
살리실산; 및
용매
를 포함하는 화장료 조성물.vegetable oil;
Alkaline agents;
Sultain-based amphoteric surfactant;
Salicylic acid; And
menstruum
Cosmetic composition comprising a.
상기 식물성 오일은 야자유, 팜유, 피마자유, 올리브유 또는 이들의 조합을 포함하는 화장료 조성물.In claim 1,
The vegetable oil is a cosmetic composition comprising palm oil, palm oil, castor oil, olive oil or a combination thereof.
상기 식물성 오일은 상기 화장료 조성물 총량에 대해 5 중량% 내지 70 중량%로 포함되는 화장료 조성물.In claim 1,
The vegetable oil is a cosmetic composition comprising 5% by weight to 70% by weight based on the total amount of the cosmetic composition.
상기 알칼리제는 KOH인 화장료 조성물.In claim 1,
The cosmetic composition of the alkali agent is KOH.
상기 알칼리제는 92% 내지 100%의 중화도를 가지는 화장료 조성물.In claim 1,
The alkali agent is a cosmetic composition having a degree of neutralization of 92% to 100%.
상기 설테인계 양쪽성 계면활성제는 상기 화장료 조성물 총량에 대해 10 중량% 내지 40 중량%로 포함되는 화장료 조성물.In claim 1,
The sultein-based amphoteric surfactant is a cosmetic composition containing 10% to 40% by weight based on the total amount of the cosmetic composition.
상기 살리실산은 상기 화장료 조성물 총량에 대해 0.5 중량% 내지 2 중량%로 포함되는 화장료 조성물.In claim 1,
The salicylic acid is a cosmetic composition containing 0.5% to 2% by weight based on the total amount of the cosmetic composition.
상기 화장료 조성물은 투명한 화장료 조성물.In claim 1,
The cosmetic composition is a transparent cosmetic composition.
상기 화장료 조성물은 클렌져 화장료 조성물인 화장료 조성물.In claim 1,
The cosmetic composition is a cosmetic composition that is a cleanser cosmetic composition.
상기 화장료 조성물은 페이셜 클렌져 화장료 조성물 또는 바디 클렌져 화장료 조성물인 화장료 조성물.In claim 9,
The cosmetic composition is a cosmetic composition of a facial cleanser cosmetic composition or a body cleanser cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190047924A KR20200124512A (en) | 2019-04-24 | 2019-04-24 | Cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190047924A KR20200124512A (en) | 2019-04-24 | 2019-04-24 | Cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200124512A true KR20200124512A (en) | 2020-11-03 |
Family
ID=73197759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190047924A KR20200124512A (en) | 2019-04-24 | 2019-04-24 | Cosmetic composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200124512A (en) |
-
2019
- 2019-04-24 KR KR1020190047924A patent/KR20200124512A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11464717B2 (en) | Oral care composition containing at least one biosurfactant and fluoride | |
JP6183849B2 (en) | Skin cleanser composition | |
EA001573B1 (en) | Skin wash composition, method of preparation and use | |
DE102005014687A1 (en) | Composition containing β-defensin 2 | |
JP2000169321A (en) | Cell activation agent and preparation for external use for skin and skin cleaning agent containing the activation agent | |
KR101687599B1 (en) | High moisturizing and mild cosmetic composition for washing | |
KR20180133170A (en) | Cleansing Cosmetic Composition Having Foam Boosting and Makeup Cleansing Properties | |
KR20140055689A (en) | Gommage type cosmetic compostion for exfoliating skin having low irritant | |
JP6134837B1 (en) | Liquid detergent composition | |
KR100789686B1 (en) | Detergent composition | |
EP2057980B1 (en) | Gel cosmetic composition | |
JP2017171625A (en) | Cleanser composition | |
JP2000226324A (en) | Liquid agent composition for cleaning/wiping and for cosmetic water | |
JP4934254B2 (en) | Weakly acidic detergent composition | |
JP2002193755A (en) | Antidandruff and anti-itching hair cosmetic and hair- shampooing cosmetic | |
EP2654699B1 (en) | Active ingredient combinations of glyceryl glucosides and one or more preservatives | |
KR20200124512A (en) | Cosmetic composition | |
KR102351914B1 (en) | Skin Cleansing Cosmetic composition for Gommage Peeling | |
KR102610349B1 (en) | Composition for washing hair or scalp with low irritant | |
JP2001072573A (en) | Cosmetic for face washing | |
JP2001031993A (en) | Creamy detergent composition | |
KR20100072811A (en) | Cosmetic composition comprising astragalus membranaceus scrub | |
KR20210032799A (en) | Cosmetic composition and detergent using the same | |
KR102646479B1 (en) | Composition for solubilization of salicylic acid | |
KR102648939B1 (en) | Cosmetic composition comprising high amaount of acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal |